Expiration date: 06/2025

Active substance:

Atropine (Atropine)

ATX

A03BA01 Atropine

Pharmacological group

m-Cholinolytics

Nosological classification (ICD-10)

J45 Asthma

K25 stomach Ulcer

K26 duodenal Ulcer

K31. 3 Pylorospasm not elsewhere classified

K52 Other non-infectious gastroenteritis and colitis

K80 Gallstone disease [cholelithiasis]

K81 Cholecystitis

K94* Diagnosis of diseases of the gastrointestinal tract

N23 renal colic, unspecified

R00. 1 bradycardia, unspecified

R05 Cough

R10. 4 other and unspecified abdominal pain

Z100 * CLASS XXII Surgical practice

The composition and form of issue

1 ampoule with 1 ml of solution for injection contains atropine sulfate 1 mg, in a cardboard box of 10 PCs.

Pharmacological action:

Pharmacological action-mydriatic, antispasmodic.

Blocks peripheral and Central m-cholinergic receptors.

Pharmacodynamics

Reduces the tone of smooth muscle organs (bronchi, abdominal organs, uterus, urinary tract), reduces the secretion of salivary, gastric, bronchial, sweat glands, pancreas, increases heart rate, relaxes the fibers of the circular muscle of the iris, dilates the pupil and increases intraocular pressure, causes accommodation paralysis. In the Central nervous system prevents cholinergic interneuronal contacts, reduces trembling and muscle tension in patients with parkinsonism, excites the respiratory center.

Indications of the drug Atropine sulfate

Ulcers disease stomach and duodenal ulcers, pilorospazme, cholecystitis, cholelithiasis, intestinal spasms and urinary tract, bradiaritmii developed as a result of an increase in vagal tone, before anesthesia and surgery (for the prevention of broncho - and laryngospasm, and reduction in the secretion of salivary and bronchial glands and cardiac vagal reflexes), x-ray examination of the gastrointestinal tract, nicotinic poisoning (including organophosphate) funds, bronchial asthma, bronchitis with the overproduction of mucus.

Contraindications:

Glaucoma, obstructive bowel and urinary tract diseases, paralytic ileus.

Side effect:

Dry mouth, dilated pupil, paresis of accommodation, tachycardia, difficulty urinating, intestinal atony, dizziness, headache.

Dosage and administration

P/ C, V / m and V — V-0, 25-1 mg (0, 25-1 ml solution).

Storage conditions of the drug Atropine sulfate

In a dark place.

Keep out of reach of children.

Shelf life of the drug Atropine sulfate

5 years.

Do not use after the expiration date indicated on the package.